Back
Amicus Therapeutics Stock Predictions
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
FOLD
Amicus Therapeutics
Last Price:
$7.36
Seasonality Move:
18.33%
7 Day Trial
ALL ACCESS PASS
$
7
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Amicus Therapeutics Stock Forecast
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 29.3% based on the past 17 years of stock performance.
-
Amicus Therapeutics has risen higher in 4 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 23.53%
-
Is Amicus Therapeutics Stock Undervalued?The current Amicus Therapeutics [FOLD] share price is $7.20. The Score for FOLD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 29.3% based on the past 17 years of stock performance.
Amicus Therapeutics Stock Rating
Sell
22
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics overpriced?
-
Amicus Therapeutics has risen higher in 4 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 23.53%
Amicus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
12.65
52-Week Low:
6.20
Prediction Charts
Market Cap:
2.2B
Price in USD:
7.20
Volume:
4.6M
Beta:
1.01
Technical Analysis
SMA50:
8.40
SMA100:
9.03
SMA200:
9.94
52-Wk Change:
-31.69%
Stock Predictions
-
Is Amicus Therapeutics stock public?Yes, Amicus Therapeutics is a publicly traded company.
-
What is the Amicus Therapeutics stock quote today?The Amicus Therapeutics stock price is 7.20 USD today.
-
How to buy Amicus Therapeutics stock online?You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-4 | 7.89 | 7.50 | 7.90 | 7.39 |
| Apr-7 | 7.30 | 7.15 | 7.54 | 6.99 |
| Apr-8 | 7.36 | 6.72 | 7.41 | 6.62 |
| Apr-9 | 6.53 | 6.89 | 7.06 | 6.20 |
| Apr-10 | 6.72 | 6.51 | 6.77 | 6.23 |
| Apr-11 | 6.50 | 6.48 | 6.78 | 6.33 |
| Apr-14 | 6.61 | 6.72 | 6.87 | 6.47 |
| Apr-15 | 6.70 | 6.90 | 6.95 | 6.70 |
| Apr-16 | 6.85 | 6.70 | 6.92 | 6.65 |
| Apr-17 | 6.64 | 6.83 | 6.88 | 6.63 |
| Apr-21 | 6.78 | 6.71 | 6.92 | 6.66 |
| Apr-22 | 6.79 | 6.91 | 6.92 | 6.72 |
| Apr-23 | 7.00 | 7.10 | 7.25 | 6.97 |
| Apr-24 | 7.14 | 7.20 | 7.21 | 7.01 |
Amicus Therapeutics Earnings
Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics Forecast Revenue Growth
Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.27 per share, and an increase next year of $0.33 per share.
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.